TD SELL $CDTX at 2.20, Supp 1.98 Resis 2.20 R11 HiLo 16% T1Y 7 buy 1.7 fwdPE -1.4 DIV N/A #Cidara The #stocks #trading #finance #market

2021-06-10
13 Views

TD SELL detected for CDTX (Cidara Therapeutics,) at the close price of 2.20 with a support level at 1.98 and a resistance at 2.20, providing an opportunity for a 11 % return. Trading at a 16 % level between the 52week high 4.45 and 52 week low 1.76. The average analyst 1-year target price is 7.0 with an average buy and a score of 1.7.

TD Sell
11 %
CDTX
2.20
Cidara Therapeutics,
HiLo
16.4 %
Support
1.98
Resistance
2.20
50DMA
2.15
200DMA
2.49
52week high
4.45
52week low
1.76
10DMA
2.08
20DMA
2.04
100 Mean
2.33
Volume
198097
AvgDayVol
571601
MarketCap
106237560
EBITDA
-71563000
Revenue
12067000
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 139 Current 181.05 MA20 119.99 Lower 396.19 Upper Bound #stocks #trading #markets #finance
Global Indicators,
1 views
Global Indicators,
1 views

HILO Index 139 Current 181.05 MA20 119.99 Lower 396.19 Upper Bound #stocks #trading #markets #finance

admin - 2021-06-24

HILO Index 139 Current 181.05 MA20 119.99 Lower 396.19 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index 5.85 Avg 28.89 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
3 views
Global Indicators,
3 views

Demark B/S Index 5.85 Avg 28.89 Std 1 Curr #stocks #trading #markets #finance

admin - 2021-06-24

Demark B/S Index 5.85 Avg 28.89 Std 1 Curr #stocks #trading #markets #finance

50/200 DMA Index -3.35 Avg 3.55 Std 0 Curr #stocks #trading #markets #finance
Global Indicators,
1 views
Global Indicators,
1 views

50/200 DMA Index -3.35 Avg 3.55 Std 0 Curr #stocks #trading #markets #finance

admin - 2021-06-24

50/200 DMA Index -3.35 Avg 3.55 Std 0 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.